Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00359242 · ClinicalTrials.gov registry record · Phase 1

The SLeeping and Intake Methods Taught to Infants and Mothers Early in Life (SLIMTIME) Project

A Phase 1 study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
Phase 1
Development phase
160
Enrollment target

NCT00359242: Completed Phase 1 study, sponsored by Milton S. Hershey Medical Center.

NCT00359242 is a Phase 1 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 160 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (167% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00359242, a Phase 1 study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
Phase 1
Development phase
160 participants
Enrollment target

Study Summary

Childhood obesity has reached epidemic proportions and its prevalence continues to rise, even among very young children. Because the current evidence base regarding potentially effective early intervention components to prevent obesity is so incomplete, it is logical to initiate obesity prevention intervention research during infancy, focusing on the two major components of the infant lifestyle, sleeping and feeding.

Interventions

  • BEHAVIORAL Infant Sleeping and Soothing
  • BEHAVIORAL Repeated Food Exposure

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2006-06
Est. Completion 2009-12
Phase Phase 1
Milton S. Hershey Medical Center

396 total trials

What the finished NCT00359242 record still lists

NCT00359242 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (167% higher).

The record links to 0 conditions, and to 2 interventions - of which Infant Sleeping and Soothing is the first listed.

NCT00359242 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00359242 about?

NCT00359242 is a clinical study titled "The SLeeping and Intake Methods Taught to Infants and Mothers Early in Life (SLIMTIME) Project". Childhood obesity has reached epidemic proportions and its prevalence continues to rise, even among very young children. Because the current evidence base regarding potentially effective early intervention components to prevent obesity is so incomplete, it is logical to initiate obesity prevention i...

What is the current status of trial NCT00359242?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 160 participants. The study started on 2006-06. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00359242?

The interventions under investigation include: Infant Sleeping and Soothing (BEHAVIORAL), Repeated Food Exposure (BEHAVIORAL).

Who is sponsoring clinical trial NCT00359242?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00359242's enrollment target sits among peer trials

160 340th of 2000 higher than 1,655 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00359242, the US trial registry maintained by the National Library of Medicine. NCT00359242 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.